Cara Therapeutics, Inc.
NASDAQ: CARA
$0.95
Closing price March 11, 2024
Thursday's top analyst upgrades and downgrades included AGNC Investment, Costco Wholesale, CrowdStrike, Dick’s Sporting Goods, Fifth Third Bancorp, General Electric, PayPal, Sabre, Six Flags...
Published:
Tuesday afternoon's top analyst upgrades and downgrades included Biogen, BP, Caterpillar, Riot Blockchain, Squarespace and more.
Published:
Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic kidney disease.
Published: